1. Home
  2. VIR vs AMRC Comparison

VIR vs AMRC Comparison

Compare VIR & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • AMRC
  • Stock Information
  • Founded
  • VIR 2016
  • AMRC 2000
  • Country
  • VIR United States
  • AMRC United States
  • Employees
  • VIR N/A
  • AMRC N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • AMRC Engineering & Construction
  • Sector
  • VIR Health Care
  • AMRC Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • AMRC Nasdaq
  • Market Cap
  • VIR 1.0B
  • AMRC 1.6B
  • IPO Year
  • VIR 2019
  • AMRC 2010
  • Fundamental
  • Price
  • VIR $7.72
  • AMRC $30.86
  • Analyst Decision
  • VIR Buy
  • AMRC Buy
  • Analyst Count
  • VIR 5
  • AMRC 12
  • Target Price
  • VIR $36.80
  • AMRC $37.11
  • AVG Volume (30 Days)
  • VIR 799.2K
  • AMRC 318.3K
  • Earning Date
  • VIR 10-31-2024
  • AMRC 11-07-2024
  • Dividend Yield
  • VIR N/A
  • AMRC N/A
  • EPS Growth
  • VIR N/A
  • AMRC 8.37
  • EPS
  • VIR N/A
  • AMRC 1.07
  • Revenue
  • VIR $78,877,000.00
  • AMRC $1,512,905,000.00
  • Revenue This Year
  • VIR N/A
  • AMRC $28.98
  • Revenue Next Year
  • VIR N/A
  • AMRC $11.51
  • P/E Ratio
  • VIR N/A
  • AMRC $28.82
  • Revenue Growth
  • VIR N/A
  • AMRC 10.34
  • 52 Week Low
  • VIR $7.12
  • AMRC $17.55
  • 52 Week High
  • VIR $13.09
  • AMRC $39.68
  • Technical
  • Relative Strength Index (RSI)
  • VIR 50.14
  • AMRC 40.03
  • Support Level
  • VIR $7.54
  • AMRC $31.83
  • Resistance Level
  • VIR $7.94
  • AMRC $35.26
  • Average True Range (ATR)
  • VIR 0.32
  • AMRC 1.58
  • MACD
  • VIR 0.08
  • AMRC -0.61
  • Stochastic Oscillator
  • VIR 73.62
  • AMRC 8.08

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of revenue from the U.S. Regions segment.

Share on Social Networks: